Search results
Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind. Learn More. Quick Links. Advancing Inclusive Research. Patient Financial Support.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Genentech has multiple medicines for serious and life-threatening medical conditions. Access information and resources on each of our medicines.
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech | 739,287 followers on LinkedIn. About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions.
Genentech develops products across a wide range of therapeutic areas, always with the goal of advancing medical science and positively impacting the lives of our patients. Review and download product resources, and learn more about our products below.
